Cytomegalovirus induction of interleukin-6 in lung fibroblasts occurs independently of active infection and involves a G protein and the transcription factor, NF-κB

Journal of Infectious Diseases

Volumn 179, Issue 5, 1999, Pages 1094-1100

  Carlquist, John F ^a,c   Edelman, Linda ^a   Bennion, Debra W ^a   Anderson, Jeffrey L ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c LDS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; ULTRAVIOLET IRRADIATION;

CELL LINE; CYTOMEGALOVIRUS; FIBROBLASTS; GTP-BINDING PROTEINS; HUMANS; INTERLEUKIN-6; LUNG; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ULTRAVIOLET RAYS; VIRAL ENVELOPE PROTEINS;

EID: 0033005556     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314734     Document Type: Article

References (22)

1. 1. Rubin RH, Tolkoff-Rubin NE, Oliver D, et al. Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 1985;40:243-9.
2. 2. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989;261:3561-6.
3. 3. Carlquist JF, Shelby J, Shao YL, Greenwood JH, Hammond EH, Anderson JL. Accelerated rejection of murine cardiac allografts by murine cytomegalovirus-infected recipients: lack of haplotype specificity. J Clin Invest 1993;91:2602-8.
4. 4. Zhou YF, Leon MB, Waclawiw MA, et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996;335:624-30.
5. 5. Nieto FJ, Adam E, Sorlie P, et al. Cohort study of Cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 1996;94:922-7.
6. 6. Manez R, Breinig MC, Linden P, et al. Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis 1997;176:1462-7.
7. 7. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993;54:1-78.
8. 8. Casiraghi F, Ruggenenti P, Noris M, et al. Sequential monitoring of urine-soluble interleukin-2 receptor and interleukin-6 predicts acute rejection of human renal allografts before clinical or laboratory signs of renal dysfunction. Transplantation 1997;63:1508-14.
9. 9. Deng MC, Erren M, Kammerling L, et al. The relation of interleukin-6, tumor necrosis factor-α, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation. Transplantation 1995;60:1118-24.
10. 10. Gorczynski RM, Adams RB, Levy RA, Chung SW. Correlation of peripheral blood lymphocyte and intragraft cytokine mRNA expression with rejection in orthotopic liver transplantation. Surgery 1996;120:496-502.
11. 11. Rus HG, Vlaicu R, Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996;127:263-71.
12. 12. Banks RE, Forbes MA, Storr M, et al. The acute phase protein response in patients receiving subcutaneous IL-6. Clin Exp Immunol 1995;102: 217-23.
13. 13. Seino Y, Ikeda U, Ikeda M, et al. Interleukin-6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 1994;6:87-91.
14. 14. Fyfe Al, Rothenberg LS, DeBeer FC, Cantor RM, Rotter JI, Lusis AJ. Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct atherosclerotic processes. Circulation 1997;96:2914-9.
15. 15. May LT, Helfgott DC, Sehgal PB. Anti β-interferon antibodies inhibit the increased expression of HLA B27 mRNA in tumor necrosis factor treated human fibroblasts: structural studies of the β-interferon involved. Proc Natl Acad Sci USA 1986;83:8957-61.
16. 16. Demmler GJ, Buffone GJ, Schimbor CM, May RA. Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification. J Infect Dis 1988;158:1177-84.
17. 17. Iwamoto GK, Konicek SA. Cytomegalovirus immediate early genes upregulate interleukin-6 gene expression. J Investig Med 1997;45:175-82.
18. 18. Shibutani T, Johnson TM, Yu ZX, Ferrans VJ, Moss J, Epstein SE. Pertussis toxin sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells. J Clin Invest 1997;100:2054-61.
19. 19. Almeida GD, Porada CD, St Jeor S, Ascensao JL. Human cytomegalovirus alters interleukin-6 production by endothelial cells. Blood 1994;83:370-6.
20. 20. Boyle KA, Compton T. Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B. J Virol 1998;72:1826-33.
21. 21. Craigen JL, Grundy JE. Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment. Transplantation 1996;62:1102-8.
22. 22. Yurochko AD, Hwang ES, Rasmussen L, Keay S, Pereira L, Huang ES. The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-κB during infection. J Virol 1997;71:5051-9.